• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CONSORT清单能否提高随机对照试验报告的质量?一项系统评价。

Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review.

作者信息

Plint Amy C, Moher David, Morrison Andra, Schulz Kenneth, Altman Douglas G, Hill Catherine, Gaboury Isabelle

机构信息

Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.

出版信息

Med J Aust. 2006 Sep 4;185(5):263-7. doi: 10.5694/j.1326-5377.2006.tb00557.x.

DOI:10.5694/j.1326-5377.2006.tb00557.x
PMID:16948622
Abstract

OBJECTIVE

To determine whether the adoption of the CONSORT checklist is associated with improvement in the quality of reporting of randomised controlled trials (RCTs).

DATA SOURCES

MEDLINE, EMBASE, Cochrane CENTRAL, and reference lists of included studies and of experts were searched to identify eligible studies published between 1996 and 2005.

STUDY SELECTION

Studies were eligible if they (a) compared CONSORT-adopting and non-adopting journals after the publication of CONSORT, (b) compared CONSORT adopters before and after publication of CONSORT, or (c) a combination of (a) and (b). Outcomes examined included reports for any of the 22 items on the CONSORT checklist or overall trial quality.

DATA SYNTHESIS

1128 studies were retrieved, of which 248 were considered possibly relevant. Eight studies were included in the review. CONSORT adopters had significantly better reporting of the method of sequence generation (risk ratio [RR], 1.67; 95% CI, 1.19-2.33), allocation concealment (RR, 1.66; 95% CI, 1.37-2.00) and overall number of CONSORT items than non-adopters (standardised mean difference, 0.83; 95% CI, 0.46-1.19). CONSORT adoption had less effect on reporting of participant flow (RR, 1.14; 95% CI, 0.89-1.46) and blinding of participants (RR, 1.09; 95% CI, 0.84-1.43) or data analysts (RR, 5.44; 95% CI, 0.73-36.87). In studies examining CONSORT-adopting journals before and after the publication of CONSORT, description of the method of sequence generation (RR, 2.78; 95% CI, 1.78-4.33), participant flow (RR, 8.06; 95% CI, 4.10-15.83), and total CONSORT items (standardised mean difference, 3.67 items; 95% CI, 2.09-5.25) were improved after adoption of CONSORT by the journal.

CONCLUSIONS

Journal adoption of CONSORT is associated with improved reporting of RCTs.

摘要

目的

确定采用CONSORT清单是否与随机对照试验(RCT)报告质量的提高相关。

数据来源

检索MEDLINE、EMBASE、Cochrane CENTRAL以及纳入研究和专家的参考文献列表,以识别1996年至2005年期间发表的符合条件的研究。

研究选择

如果研究符合以下条件则纳入:(a)在CONSORT发表后比较采用和未采用CONSORT的期刊;(b)比较CONSORT采用者在CONSORT发表前后的情况;或(c)(a)和(b)的组合。检查的结果包括CONSORT清单上22项中的任何一项的报告或总体试验质量。

数据综合

检索到1128项研究,其中248项被认为可能相关。8项研究纳入综述。与未采用者相比,采用CONSORT的研究者在序列产生方法的报告方面显著更好(风险比[RR],1.67;95%置信区间[CI],1.19 - 2.33)、分配隐藏(RR,1.66;95%CI,1.37 - 2.00)以及CONSORT项目的总数(标准化均值差,0.83;95%CI,0.46 - 1.19)。采用CONSORT对参与者流程报告(RR,1.14;95%CI,0.89 - 1.46)、参与者设盲(RR,1.09;95%CI,0.84 - 1.43)或数据分析师设盲(RR,5.44;95%CI,0.73 - 36.87)的影响较小。在研究CONSORT发表前后采用CONSORT的期刊的研究中,期刊采用CONSORT后,序列产生方法的描述(RR,2.78;95%CI,1.78 - 4.33)、参与者流程(RR,8.06;95%CI,4.10 - 15.83)以及CONSORT项目总数(标准化均值差,3.67项;95%CI,2.09 - 5.25)均有所改善。

结论

期刊采用CONSORT与RCT报告质量的提高相关。

相似文献

1
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review.CONSORT清单能否提高随机对照试验报告的质量?一项系统评价。
Med J Aust. 2006 Sep 4;185(5):263-7. doi: 10.5694/j.1326-5377.2006.tb00557.x.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.试验报告的统一标准(CONSORT)以及医学期刊上发表的随机对照试验(RCT)的报告完整性。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2.
4
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3.
5
Reporting quality of trial abstracts-improved yet suboptimal: A systematic review and meta-analysis.研究摘要报告质量——有所改善但仍不理想:系统评价和荟萃分析。
J Evid Based Med. 2018 May;11(2):89-94. doi: 10.1111/jebm.12294. Epub 2018 Feb 20.
6
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2017 Oct 31;10(10):CD012024. doi: 10.1002/14651858.CD012024.pub2.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Treatments for seizures in catamenial (menstrual-related) epilepsy.月经性(与月经相关)癫痫发作的治疗。
Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3.
9
Interventions for infantile haemangiomas of the skin.皮肤婴儿血管瘤的干预措施。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.
10
Face-to-face interventions for informing or educating parents about early childhood vaccination.针对向父母宣传或教育幼儿疫苗接种情况的面对面干预措施。
Cochrane Database Syst Rev. 2018 May 8;5(5):CD010038. doi: 10.1002/14651858.CD010038.pub3.

引用本文的文献

1
CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation.CONSORT 2025声明:报告随机试验的更新指南:韩文译本
Ewha Med J. 2025 Jul;48(3):e50. doi: 10.12771/emj.2025.00409. Epub 2025 Jul 2.
2
[Sex and Gender Equity in Research (SAGER): rationale for the SAGER guidelines and recommended use: a Korean translation].[研究中的性别平等(SAGER):SAGER指南的基本原理及推荐用法:韩文译本]
Ewha Med J. 2024 Jan;47(1):e10. doi: 10.12771/emj.2024.e10. Epub 2024 Jan 31.
3
Group-based trajectory modeling for supportive care needs in Chinese cancer survivors: A systematic review.
中国癌症幸存者支持性护理需求的基于群体的轨迹建模:一项系统综述。
Asia Pac J Oncol Nurs. 2025 Jun 6;12:100738. doi: 10.1016/j.apjon.2025.100738. eCollection 2025 Dec.
4
Recommendations for a Complete Reporting of Statistical Methods in Veterinary Pharmacology.兽医药理学统计方法完整报告的建议。
J Vet Pharmacol Ther. 2025 Jul;48(4):221-233. doi: 10.1111/jvp.70001. Epub 2025 Jun 6.
5
Dissemination planning in exercise oncology trials-a systematic review of trial protocols.运动肿瘤学试验中的传播规划——试验方案的系统评价
Support Care Cancer. 2025 May 15;33(6):473. doi: 10.1007/s00520-025-09532-4.
6
Assessment of Quality in Antimicrobial Calcium Phosphate Research (AQUACAP): A Systematic Review.抗菌磷酸钙研究中的质量评估(AQUACAP):一项系统综述。
Materials (Basel). 2025 Mar 28;18(7):1543. doi: 10.3390/ma18071543.
7
The methodological reporting quality in strictly randomized controlled trials for COVID-19 and precise reporting of Chinese herbal medicine formula intervention.新型冠状病毒肺炎严格随机对照试验的方法学报告质量及中药方剂干预的精准报告
Front Pharmacol. 2025 Mar 31;16:1532290. doi: 10.3389/fphar.2025.1532290. eCollection 2025.
8
CONSORT 2025 statement: updated guideline for reporting randomized trials.CONSORT 2025声明:报告随机试验的更新指南
Nat Med. 2025 Apr 15. doi: 10.1038/s41591-025-03635-5.
9
CONSORT 2025 statement: updated guideline for reporting randomised trials.CONSORT 2025声明:随机对照试验报告的更新指南
BMJ. 2025 Apr 14;389:e081123. doi: 10.1136/bmj-2024-081123.
10
CONSORT 2025 statement: Updated guideline for reporting randomised trials.CONSORT 2025声明:报告随机试验的更新指南。
PLoS Med. 2025 Apr 14;22(4):e1004587. doi: 10.1371/journal.pmed.1004587. eCollection 2025 Apr.